Delivery Order SPE2DX22D0010-SPE2D824FNA14

Award Date 6/4/24
Potential Completion Date 6/5/24
Potential Value $1.1K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a Delivery Order under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. The contract provides for the delivery of a comprehensive range of pharmaceutical products and medical supplies, including specialty, brand name, generic, and over-the-counter medications, as well as critical care materials...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a Delivery Order under the company's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. The contract provides for the delivery of a comprehensive range of pharmaceutical products and medical supplies, including specialty, brand name, generic, and over-the-counter medications, as well as critical care...
This federal contract award was made to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distribution company, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at up to $999,999,999.00 through December 31, 2025, is an Indefinite Delivery Contract (IDC) that serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a Delivery Order under the company's existing Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. The contract provides for the delivery of a comprehensive range of pharmaceutical products and medical supplies, including specialty, brand name, generic, and over-the-counter medications, as well as...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division by the Defense Logistics Agency (DLA) Troop Support Medical is for the delivery of pharmaceutical products and medical supplies, including prescription medications, over-the-counter drugs, and critical care materials such as syringes and test kits. The contract, valued at up to $999,999,999.00 through December 31, 2025, is an Indefinite Delivery Contract (IDC) that serves as the primary vehicle for...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a Delivery Order under the company's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. The contract is for the provision of a comprehensive range of pharmaceutical products and medical supplies, including specialty, brand name, generic, and over-the-counter medications, as well as critical care...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of a wide range of pharmaceutical products and medical supplies to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at up to $999,999,999.00 through December 31, 2025, is an Indefinite Delivery Contract (IDC) that serves as the primary vehicle for Amerisourcebergen to provide specialty, brand name, generic, and over-the-counter medications, as well as...
This is a federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of a comprehensive range of pharmaceutical products and medical supplies, including specialty, brand name, generic, and over-the-counter medications, as well as critical care materials such as syringes, vials, and test kits. The contract is an Indefinite Delivery Contract...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of pharmaceutical products and medical supplies to the U.S. Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at up to $999,999,999.00 through December 31, 2025, is an Indefinite Delivery Contract (IDC) that serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of medications, including specialty, brand name, generic, and...
This federal contract award to Amerisourcebergen Drug Corporation's Corporate Office Division provides for the delivery of a wide range of pharmaceutical products and medical supplies to the Defense Logistics Agency (DLA) Troop Support Medical. The contract is an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 through December 31, 2025, and serves as the primary vehicle for Amerisourcebergen to deliver specialty, brand name, generic, and over-the-counter medications, as well...
  • SPE2DX22D0010
    Indefinite Delivery Contract
  • SPE2DX22D0010-SPE2D824FNA14
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a delivery order under the company's existing Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. The contract is for the provision of a wide range of pharmaceutical products and medical supplies, including specialty, brand name, generic, and over-the-counter medications, as well as critical care materials such as syringes, vials, and test kits. This contract does not have a set-aside designation and is awarded on a full and open competition basis, highlighting Amerisourcebergen's competitive position in the federal pharmaceutical supply market. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024. This contract award supports the DLA's mission to provide logistics, acquisition, and technical services to the U.S. Armed Forces and other government agencies.

Generated 9/3/24, 12:08 PM